Adenoviral‐mediated transfer of human BMP‐6 gene accelerates healing in a rabbit ulnar osteotomy model

This study evaluated healing of rabbit bilateral ulnar osteotomies 6 and 8 weeks after surgery in response to percutaneous injection of transgenic adenoviral (Ad) bone morphogenetic protein‐6 (BMP‐6) vector or green fluorescent protein vector control (Ad‐GFP) administered 7 days after surgery compared to untreated osteotomy controls. The amount, composition and biomechanical properties of the healing bone repair tissue were compared among groups and to historical data for intact rabbit ulnae obtained from similar studies at the same institution. Quantitative computed tomography was used to determine area, density and mineral content of the mineralized callus in the harvested ulnae. Maximum torque, torsional stiffness, and energy absorbed to failure were determined at 1.5°/s. Calcified sections of excised ulnae (5 μm) were stained with Goldner's Trichrome and Von Kossa, and evaluated for callus composition, maturity, cortical continuity, and osteotomy bridging. Radiographic assessment of bone formation indicated greater mineralized callus in the ulnae injected with Ad‐hBMP‐6 as early as 1 week after treatment (2 weeks after surgery) compared to untreated osteotomy ulnae (P < 0.006) and Ad‐GFP treated osteotomy ulnae (p < 0.002). Quantitative computed tomography confirmed greater bone area and bone mineral content at the osteotomy at 6 weeks in Ad‐BMP‐6 treated osteotomy as compared to untreated osteotomy ulnae (p < 0.001) and Ad‐GFP treated osteotomy ulnae (p < 0.01). Ad‐BMP‐6 treated osteotomy ulnae were stronger (p < 0.001 and 0.003) and stiffer (p = 0.004 and 0.003) in torsion at 6 weeks than untreated osteotomy ulnae or Ad‐GFP treated osteotomy ulnae, respectively. Maximum torque, torsional stiffness, and energy absorbed to failure were greater in Ad‐BMP‐6 treated osteotomy ulnae compared to their respective untreated contralateral osteotomy ulnae at 8 weeks [p < 0.03]. Maximum torque and torsional stiffness in the Ad‐BMP‐6 treated osteotomy ulnae were not different to intact ulnae values at 6 and 8 weeks. These experiments confirm that BMP‐6 can be potently osteoinductive in vivo resulting in acceleration of bone repair. © 2004 Orthopaedic Research Society. Published by Elsevier Ltd. All rights reserved.

[1]  F. Hughes,et al.  The effects of bone morphogenetic protein-2, -4, and -6 on differentiation of rat osteoblast cells in vitro. , 1995, Endocrinology.

[2]  S. Doty,et al.  BMP‐6 accelerates both chondrogenesis and mineral maturation in differentiating chick limb‐bud mesenchymal cell cultures , 2002, Journal of cellular biochemistry.

[3]  J. Huard,et al.  Adenovirus mediated gene transfer to skeletal muscle , 2002, Microscopy research and technique.

[4]  L. Titus,et al.  Overcoming the Immune Response to Permit Ex Vivo Gene Therapy for Spine Fusion With Human Type 5 Adenoviral Delivery of the LIM Mineralization Protein-1 cDNA , 2003, Spine.

[5]  S. Miyatake,et al.  Osteoinduction by bone morphogenetic protein-2 via adenoviral vector under transient immunosuppression. , 2000, Biochemical and biophysical research communications.

[6]  G. Zych,et al.  Osteogenic Protein-1 (Bone Morphogenetic Protein-7) in the Treatment of Tibial Nonunions: A Prospective, Randomized Clinical Trial Comparing rhOP-1 with Fresh Bone Autograft* , 2001, The Journal of bone and joint surgery. American volume.

[7]  V. Rosen,et al.  Identification of transforming growth factor beta family members present in bone-inductive protein purified from bovine bone. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[8]  P. Robbins,et al.  Increased matrix synthesis following adenoviral transfer of a transforming growth factor β1 gene into articular chondrocytes , 2000, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[9]  J. Engh,et al.  Use of bone morphogenetic protein-9 gene therapy to induce spinal arthrodesis in the rodent. , 2000, Journal of neurosurgery.

[10]  H. Seeherman,et al.  Recombinant Human Bone Morphogenetic Protein‐2 Enhances Osteotomy Healing in Glucocorticoid‐Treated Rabbits , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[11]  Johnny Huard,et al.  Enhancement of bone healing based on ex vivo gene therapy using human muscle-derived cells expressing bone morphogenetic protein 2. , 2002, Human gene therapy.

[12]  D. Oakes,et al.  Osteoinductive applications of regional gene therapy: ex vivo gene transfer. , 2000, Clinical orthopaedics and related research.

[13]  P. Maniscalco,et al.  Healing of fresh tibial fractures with OP-1. A preliminary report. , 2002, Acta bio-medica : Atenei Parmensis.

[14]  H. Seeherman,et al.  Recombinant Human Bone Morphogenetic Protein-2 Accelerates Healing in a Rabbit Ulnar Osteotomy Model , 2001, The Journal of bone and joint surgery. American volume.

[15]  Naohisa Miyakoshi,et al.  In vivo bone formation in fracture repair induced by direct retroviral-based gene therapy with bone morphogenetic protein-4. , 2003, Bone.

[16]  G. Finerman,et al.  Regional gene therapy with a BMP‐2‐producing murine stromal cell line induces heterotopic and orthotopic bone formation in rodents , 1998, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[17]  S. Miyatake,et al.  In Vitro and in Vivo Studies of a Bone Morphogenetic Protein-2 Expressing Adenoviral Vector , 2001, The Journal of bone and joint surgery. American volume.

[18]  S. Santavirta,et al.  Recombinant Human Bone Morphogenetic Protein-2 for Treatment of Open Tibial Fractures: A Prospective, Controlled, Randomized Study of Four Hundred and Fifty Patients , 2002, The Journal of bone and joint surgery. American volume.

[19]  B. Hogan,et al.  Mice lacking Bmp6 function. , 1998, Developmental genetics.

[20]  N. Wright,et al.  Thoracoscopic Intradiscal Spine Fusion Using a Minimally Invasive Gene-Therapy Technique , 2003, The Journal of bone and joint surgery. American volume.

[21]  R. J. Dumont,et al.  Ex Vivo Bone Morphogenetic Protein-9 Gene Therapy Using Human Mesenchymal Stem Cells Induces Spinal Fusion in Rodents , 2002, Neurosurgery.

[22]  Christian Lattermann,et al.  A gene therapy approach to accelerating bone healing Evaluation of gene expression in a New Zealand white rabbit model , 1999, Knee Surgery, Sports Traumatology, Arthroscopy.

[23]  P. Aspenberg,et al.  Randomized Radiostereometric Study Comparing Osteogenic Protein-1 (BMP-7) and Autograft Bone in Human Noninstrumented Posterolateral Lumbar Fusion: 2002 Volvo Award in Clinical Studies , 2002, Spine.

[24]  J. Lou,et al.  Gene therapy: Adenovirus‐mediated human bone morphogenetic protein‐2 gene transfer induces mesenchymal progenitor cell proliferation and differentiation in vitro and bone formation in vivo , 1999, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[25]  S. Boden,et al.  Use of Recombinant Human Bone Morphogenetic Protein-2 to Achieve Posterolateral Lumbar Spine Fusion in Humans: A Prospective, Randomized Clinical Pilot Trial 2002 Volvo Award in Clinical Studies , 2002, Spine.

[26]  A. Davis,et al.  Adenovirus‐mediated BMP2 expression in human bone marrow stromal cells , 2001, Journal of cellular biochemistry.

[27]  T A Einhorn,et al.  Growth Factor Regulation of Fracture Repair , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[28]  S. Vukicevic,et al.  Expression of bone morphogenetic proteins and cartilage‐derived morphogenetic proteins during osteophyte formation in humans , 2003, Journal of anatomy.

[29]  C. McIlwraith,et al.  Treatment of experimental equine osteoarthritis by in vivo delivery of the equine interleukin-1 receptor antagonist gene , 2002, Gene Therapy.

[30]  C T Laurencin,et al.  Poly(lactide-co-glycolide)/hydroxyapatite delivery of BMP-2-producing cells: a regional gene therapy approach to bone regeneration. , 2001, Biomaterials.

[31]  P. Robbins,et al.  Direct gene delivery strategies for the treatment of rheumatoid arthritis. , 2001, Drug discovery today.

[32]  P. Robbins,et al.  Genetic enhancement of fracture repair: healing of an experimental segmental defect by adenoviral transfer of the BMP-2 gene , 2000, Gene Therapy.

[33]  D. Gazit,et al.  Engineered pluripotent mesenchymal cells integrate and differentiate in regenerating bone: a novel cell‐mediated gene therapy , 1999, The journal of gene medicine.

[34]  J. Engh,et al.  The Use of Bone Morphogenetic Protein Gene Therapy in Craniofacial Bone Repair , 2000, The Journal of craniofacial surgery.

[35]  P. Robbins,et al.  Potential treatment of osteoarthritis by gene therapy. , 1999, Rheumatic diseases clinics of North America.

[36]  J. Engh,et al.  In vivo endochondral bone formation using a bone morphogenetic protein 2 adenoviral vector. , 1999, Human gene therapy.

[37]  R. J. Dumont,et al.  Human mesenchymal stem cells transduced with recombinant bone morphogenetic protein-9 adenovirus promote osteogenesis in rodents. , 2003, Tissue engineering.

[38]  Hak-Sun Kim,et al.  Simple Carrier Matrix Modifications Can Enhance Delivery of Recombinant Human Bone Morphogenetic Protein-2 for Posterolateral Spine Fusion , 2003, Spine.

[39]  D. Hu,et al.  LMP-1, a LIM-domain protein, mediates BMP-6 effects on bone formation. , 1998, Endocrinology.

[40]  Adam J Starr,et al.  Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures. , 2003, The Journal of bone and joint surgery. American volume.

[41]  Jing Wu,et al.  Enhancement of bone repair with a helper-dependent adenoviral transfer of bone morphogenetic protein-2. , 2002, Biochemical and biophysical research communications.

[42]  J. Tobias,et al.  Increased Bone Morphogenetic Protein‐6 Expression in Mouse Long Bones After Estrogen Administration , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[43]  M. Bostrom,et al.  Expression of bone morphogenetic proteins in fracture healing. , 1998, Clinical orthopaedics and related research.

[44]  A. Marmarou,et al.  Use of magnetic resonance imaging for in vivo measurements of water content in human brain: method and normal values. , 1999, Journal of neurosurgery.

[45]  C. Evans,et al.  Gene transfer approaches to the healing of bone and cartilage. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[46]  Y. Mishina,et al.  BMPs and BMP receptors in mouse metanephric development: in vivo and in vitro studies. , 2002, The International journal of developmental biology.

[47]  K. Yoshimura,et al.  Heterotopic Ossification of Degenerating Rat Skeletal Muscle Induced by Adenovirus‐Mediated Transfer of Bone Morphogenetic Protein‐2 Gene , 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[48]  H. Seeherman,et al.  The effect of recombinant human bone morphogenetic protein‐2 on femoral reconstruction with an intercalary allograft in a dog model , 2001, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[49]  R. Johnson,et al.  Interaction of Ihh and BMP/Noggin signaling during cartilage differentiation. , 1999, Developmental biology.

[50]  D. Hu,et al.  Molecular aspects of healing in stabilized and non‐stabilized fractures , 2001, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[51]  D. Kallmes,et al.  Ectopic osteogenesis using adenoviral bone morphogenetic protein (BMP)-4 and BMP-6 gene transfer. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[52]  H. Seeherman,et al.  The safety and utility of recombinant human bone morphogenetic protein-2 for cranial procedures in a nonhuman primate model. , 2003, Journal of neurosurgery.

[53]  H. Seeherman,et al.  rhBMP‐2 injected in a calcium phosphate paste (α‐BSM) accelerates healing in the rabbit ulnar osteotomy model , 2003, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[54]  P. Robbins,et al.  Adenovirus-mediated direct gene therapy with bone morphogenetic protein-2 produces bone. , 1999, Bone.

[55]  A. Scaduto,et al.  Gene therapy for osteoinduction. , 1999, The Orthopedic clinics of North America.

[56]  Johnny Huard,et al.  BMP4-expressing muscle-derived stem cells differentiate into osteogenic lineage and improve bone healing in immunocompetent mice. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

[57]  P. Campbell,et al.  Effect of Regional Gene Therapy with Bone Morphogenetic Protein-2-Producing Bone Marrow Cells on Spinal Fusion in Rats , 2003, The Journal of bone and joint surgery. American volume.

[58]  H. Seeherman,et al.  Bone consolidation is enhanced by rhBMP‐2 in a rabbit model of distraction osteogenesis , 2002, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[59]  W Gaffield,et al.  BMP and Ihh/PTHrP signaling interact to coordinate chondrocyte proliferation and differentiation. , 2001, Development.

[60]  R. Müller,et al.  Engineered human mesenchymal stem cells: a novel platform for skeletal cell mediated gene therapy , 2001, The journal of gene medicine.

[61]  L. Titus,et al.  Mechanism of Bone Formation with Gene Transfer of the cDNA Encoding for the Intracellular Protein LMP-1 , 2003, The Journal of bone and joint surgery. American volume.

[62]  Freddie H. Fu,et al.  Effect of Bone Morphogenetic Protein-2-Expressing Muscle-Derived Cells on Healing of Critical-Sized Bone Defects in Mice , 2001, The Journal of bone and joint surgery. American volume.

[63]  R. Müller,et al.  Exogenously regulated stem cell-mediated gene therapy for bone regeneration. , 2001, Molecular therapy : the journal of the American Society of Gene Therapy.

[64]  H. Seeherman,et al.  Histomorphometric description of allograft bone remodeling and union in a canine segmental femoral defect model: A comparison of rhBMP‐2, cancellous bone graft, and absorbable collagen sponge , 2001, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[65]  D. Kallmes,et al.  Percutaneous spinal fusion using bone morphogenetic protein-2 gene therapy. , 1999, Journal of neurosurgery.